Liquidia Corporation (LQDA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
419 Davis Drive
Morrisville, NC 27560
United States of America (the)
Phone
919 328 4400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
216
First IPO Date
July 26, 2018
| Name | Title | Pay | Year Born |
| Roger A. Jeffs | Chief Executive Officer & Director | 2.12M | 1962 |
| Scott Moomaw | Chief Commercial Officer | 980,961 | 1971 |
| Rajeev Saggar | Chief Medical Officer | 1.17M | 1975 |
| Russell Schundler | General Counsel & Corporate Secretary | 1.17M | 1976 |
| Michael Kaseta | Chief Operating Officer & Chief Financial Officer | 1.41M | 1976 |
| Dana Boyle | Chief Accounting Officer | 0 | 1985 |
| Matt Snow | Senior Vice President of Sales | 0 | N/A |
| Michael Post | Senior Vice President of Marketing | 0 | N/A |
| Sarah Krepp SPHR | Chief Human Resources Officer | 0 | 1982 |
| Christian Perez Font | Senior Vice President, Chief Compliance Officer & Associate General Counsel | 0 | N/A |
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.